Verona Pharma Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Verona Pharma stock have an average target of 66.83, with a low estimate of 36 and a high estimate of 93. The average target predicts an increase of 7.59% from the current stock price of 62.12.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$36	$66.83	$72	$93
Change	-42.04%	+7.59%	+15.91%	+49.72%

* Price targets were last updated on Feb 28, 2025.

Analyst Ratings

The average analyst rating for Verona Pharma stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	3	3	3	4	4	4
Buy	3	3	3	3	3	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	7	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tiago Fauth Wells Fargo	Wells Fargo	Buy Maintains $74 → $93	Buy	Maintains	$74 → $93	+49.72%	Feb 28, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $60 → $75	Strong Buy	Maintains	$60 → $75	+20.74%	Feb 28, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $44 → $72	Strong Buy	Maintains	$44 → $72	+15.91%	Feb 12, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $42 → $60	Strong Buy	Reiterates	$42 → $60	-3.40%	Jan 21, 2025
Boobalan Pachaiyappan Roth MKM	Roth MKM	Strong Buy Initiates $68	Strong Buy	Initiates	$68	+9.47%	Jan 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

312.66M

from 42.28M

639.52%

from 42.28M

Revenue Next Year

598.97M

from 312.66M

91.57%

from 312.66M

EPS This Year

-0.12

from -2.16

EPS Next Year

1.86

from -0.12

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	40.00M	458.00K	-	42.28M	312.66M	598.97M	835.43M
Revenue Growth	-	-	-98.86%	-	-	639.52%	91.57%	39.48%
EPS	-1.98	-0.94	-1.04	-0.72	-2.16	-0.12	1.86	1.16
EPS Growth	-	-	-	-	-	-	-	-37.90%
Forward PE	-	-	-	-	-	-	33.37	53.73
No. Analysts	-	-	-	-	-	8	4	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	418.9M	857.0M	1.2B
Avg	312.7M	599.0M	835.4M
Low	259.7M	460.7M	649.0M

Revenue Growth

Revenue Growth	2025	2026	2027
High	890.7%	174.1%	106.2%
Avg	639.5%	91.6%	39.5%
Low	514.3%	47.4%	8.3%

EPS Forecast

EPS	2025	2026	2027
High	0.17	2.26	1.92
Avg	-0.12	1.86	1.16
Low	-0.67	1.47	0.17

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	3.2%
Avg	-	-	-37.9%
Low	-	-	-91.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.